EPS for AvalonBay Communities (AVB) Expected At $2.13; Amphastar Pharmaceuticals (AMPH) Sentiment Is 1.32

July 17, 2017 - By Vivian Park

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company has market cap of $825.56 million. The Firm focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. It has a 94.99 P/E ratio. The Firm has two divisions: finished pharmaceutical products and active pharmaceutical ingredients products.

Analysts expect AvalonBay Communities Inc (NYSE:AVB) to report $2.13 EPS on August, 2 after the close.They anticipate $0.10 EPS change or 4.93% from last quarter’s $2.03 EPS. AVB’s profit would be $294.73 million giving it 22.27 P/E if the $2.13 EPS is correct. After having $2.09 EPS previously, AvalonBay Communities Inc’s analysts see 1.91% EPS growth. About 150,977 shares traded. AvalonBay Communities Inc (NYSE:AVB) has risen 6.66% since July 17, 2016 and is uptrending. It has underperformed by 10.04% the S&P500.

AvalonBay Communities, Inc. is a real estate investment trust . The company has market cap of $26.25 billion. The Firm is focused on the development, redevelopment, acquisition, ownership and operation of multifamily communities primarily in New England, the New York/New Jersey metro area, the Mid-Atlantic, the Pacific Northwest, and Northern and Southern California. It has a 25.35 P/E ratio. The Company’s divisions include Established Communities, Other Stabilized Communities and Development/Redevelopment Communities.

Among 19 analysts covering Avalonbay Communities Inc. (NYSE:AVB), 10 have Buy rating, 1 Sell and 8 Hold. Therefore 53% are positive. Avalonbay Communities Inc. had 43 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Monday, July 3. Jefferies downgraded AvalonBay Communities Inc (NYSE:AVB) on Wednesday, June 8 to “Hold” rating. Sandler O’Neill upgraded AvalonBay Communities Inc (NYSE:AVB) on Tuesday, September 6 to “Buy” rating. BMO Capital Markets downgraded the stock to “Market Perform” rating in Monday, March 7 report. JMP Securities initiated AvalonBay Communities Inc (NYSE:AVB) on Friday, January 8 with “Market Perform” rating. The stock has “Hold” rating by BMO Capital Markets on Friday, May 26. On Wednesday, November 18 the stock rating was maintained by Deutsche Bank with “Buy”. The stock of AvalonBay Communities Inc (NYSE:AVB) earned “Neutral” rating by Bank of America on Wednesday, November 23. The firm has “Buy” rating given on Tuesday, September 8 by Evercore. Suntrust Robinson maintained AvalonBay Communities Inc (NYSE:AVB) on Friday, October 16 with “Buy” rating.

Since March 1, 2017, it had 0 insider buys, and 15 selling transactions for $11.35 million activity. HOREY LEO S III had sold 3,000 shares worth $570,750. On Tuesday, March 7 Wilson Stephen W sold $706,005 worth of AvalonBay Communities Inc (NYSE:AVB) or 3,877 shares. 3,000 shares valued at $547,882 were sold by SCHULMAN EDWARD M on Monday, March 6. McLaughlin William M sold $991,115 worth of stock. 2,750 AvalonBay Communities Inc (NYSE:AVB) shares with value of $525,803 were sold by Birenbaum Matthew H.. $192,362 worth of AvalonBay Communities Inc (NYSE:AVB) was sold by Shea Keri A. NAUGHTON TIMOTHY J sold 17,210 shares worth $3.31 million.

Investors sentiment increased to 1.02 in Q4 2016. Its up 0.23, from 0.79 in 2016Q3. It is positive, as 36 investors sold AvalonBay Communities Inc shares while 143 reduced holdings. 44 funds opened positions while 139 raised stakes. 130.56 million shares or 0.50% more from 129.91 million shares in 2016Q3 were reported. 7,127 are held by Blair William & Il. Finemark National Bank & Trust & invested 0.21% in AvalonBay Communities Inc (NYSE:AVB). Metropolitan Life New York owns 76,166 shares for 0.1% of their portfolio. Advantus Cap Management stated it has 212,696 shares or 1.01% of all its holdings. Livforsakringsbolaget Skandia Omsesidigt holds 0.08% of its portfolio in AvalonBay Communities Inc (NYSE:AVB) for 9,075 shares. Calamos Limited Liability Com invested 0.02% of its portfolio in AvalonBay Communities Inc (NYSE:AVB). Macquarie Grp has invested 0.09% in AvalonBay Communities Inc (NYSE:AVB). First L P reported 143,922 shares or 0.08% of all its holdings. Putnam Invests Lc has 0.01% invested in AvalonBay Communities Inc (NYSE:AVB). Virtu Financial Limited Company holds 3,102 shares or 0.06% of its portfolio. Cibc Asset Mngmt has invested 0.02% in AvalonBay Communities Inc (NYSE:AVB). Hexavest Incorporated stated it has 0.37% of its portfolio in AvalonBay Communities Inc (NYSE:AVB). Usca Ria Limited Liability stated it has 2,370 shares or 0.06% of all its holdings. Kcg Incorporated invested in 0.04% or 8,469 shares. Geode Capital Mgmt Lc holds 1.50M shares or 0.12% of its portfolio.

Analysts await Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) to report earnings on August, 14. They expect $0.06 EPS, down 57.14% or $0.08 from last year’s $0.14 per share. AMPH’s profit will be $2.74 million for 75.29 P/E if the $0.06 EPS becomes a reality. After $0.03 actual EPS reported by Amphastar Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts 100.00% EPS growth.

Eam Investors Llc holds 0.42% of its portfolio in Amphastar Pharmaceuticals Inc for 173,018 shares. Globeflex Capital L P owns 50,686 shares or 0.23% of their US portfolio. Moreover, Kalmar Investments Inc De has 0.23% invested in the company for 240,648 shares. The Massachusetts-based Essex Investment Management Co Llc has invested 0.19% in the stock. Oberweis Asset Management Inc, a Illinois-based fund reported 27,200 shares.

About 65,276 shares traded. Amphastar Pharmaceuticals Inc (AMPH) has risen 8.19% since July 17, 2016 and is uptrending. It has underperformed by 8.51% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.